SGP SpyGlass Pharma, Inc. - Common Stock
$19.96
Price · Jun 25, 2026
Fundamentals as of May 14, 2026
52W Range
$17–$32
19% of range
Analyst Rating
STRONG BUY
9 analysts
Price Target
$45
+125% upside
P/E (TTM)
—
ROE
50.0%
Net Profit Margin
—
SGP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$19.96
Market Cap
—
P/E (TTM)
—
EPS (TTM)
$-17.98
Revenue (TTM)
—
Div Yield
—
ROE
50.0%
Debt/Equity
—
52W Range
$17 – $32
SGP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-17.98
2024-12-31
→
2025-12-31
Free Cash Flow
$-33M
2025-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SGP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SGP
Peer Median
ROA
-57.3%
—
ROE
50.0%
—
ROIC
41.9%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SGP
Peer Median
Current Ratio
12.7
—
Quick Ratio
11.2
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SGP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SGP
Peer Median
SGP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 5 55.6%
- Buy 3 33.3%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-06-27
Median
$42.00
Mean
$45.00
← Below all targets
$19.96
Low
$37.00
High
$62.00
Median target
$42.00
+110.4%
Mean target
$45.00
+125.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.18%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.69 | $-0.51 | -0.18% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SGP | — | — | — | — | 50.0% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $29M | $20M | |
| SG&A Expense | $12M | $7M | |
| Operating Expenses | $41M | $27M | |
| Operating Income | $-41M | $-27M | |
| Interest Income | $3M | $1M | |
| Other Non-op | $2M | $-2M | |
| Pretax Income | $-40M | $-29M | |
| Income Tax | $0 | $0 | |
| Net Income | $-40M | $-29M | |
| EPS (Basic) | $-17.98 | $-16.31 | |
| EPS (Diluted) | $-17.98 | $-16.31 | |
| Shares (Basic) | 2,217,104 | 1,788,211 | |
| Shares (Diluted) | 2,217,104 | 1,788,211 | |
| EBITDA | $-41M | · |
Balance Sheet 18
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $96M | $16M | |
| Prepaid Expense | $901.0K | $715.0K | |
| Current Assets | $109M | $17M | |
| PP&E (Net) | $2M | $2M | |
| PP&E (Gross) | $3M | $3M | |
| Accum. Depreciation | $1M | $543.0K | |
| Other Non-current Assets | $492.0K | $453.0K | |
| Total Assets | $116M | $23M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $9M | $8M | |
| Capital Leases | $2M | $3M | |
| Total Liabilities | $10M | $11M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $6M | $4M | |
| Retained Earnings | $-105M | $-65M | |
| Stockholders' Equity | $-99M | $-60M | |
| Liabilities + Equity | $116M | $23M | |
| Shares Outstanding | 2,203,620 | 2,196,423 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $3M | $1M | |
| Deferred Tax | $-10M | $-7M | |
| Operating Cash Flow | $-33M | $-22M | |
| CapEx | $789.0K | $2M | |
| Investing Cash Flow | $-12M | $22M | |
| Stock Repurchased | $1M | $0 | |
| Net Stock Activity | $-1M | · | |
| Financing Cash Flow | $125M | $185.0K | |
| Net Change in Cash | $80M | $419.0K | |
| Taxes Paid | $1.0K | $18.0K | |
| Free Cash Flow | $-33M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -57.3% | · | |
| ROE | 50.0% | · | |
| ROIC | 41.9% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 12.7 | · | |
| Quick Ratio | 11.2 | · |
Valuation (TTM) 1
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-40M | · |
Income Statement 14
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| R&D Expense | $9M | · | $6M | |
| SG&A Expense | $7M | · | $1M | |
| Operating Expenses | $15M | · | $7M | |
| Operating Income | $-15M | · | $-7M | |
| Interest Income | $2M | · | $126.0K | |
| Other Non-op | $2M | · | $-1M | |
| Pretax Income | $-14M | · | $-9M | |
| Income Tax | $0 | · | $0 | |
| Net Income | $-14M | · | $-9M | |
| EPS (Basic) | $-0.69 | · | $-3.96 | |
| EPS (Diluted) | $-0.69 | · | $-3.96 | |
| Shares (Basic) | 19,927,848 | · | 2,229,637 | |
| Shares (Diluted) | 19,927,848 | · | 2,229,637 | |
| EBITDA | $-15M | · | · |
Balance Sheet 18
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $239M | $96M | · | |
| Prepaid Expense | $2M | $901.0K | · | |
| Current Assets | $253M | $109M | · | |
| PP&E (Net) | $3M | $2M | · | |
| PP&E (Gross) | $4M | $3M | · | |
| Accum. Depreciation | $1M | $1M | · | |
| Other Non-current Assets | $789.0K | $492.0K | · | |
| Total Assets | $258M | $116M | · | |
| Accounts Payable | $4M | $3M | · | |
| Current Liabilities | $7M | $9M | · | |
| Capital Leases | $2M | $2M | · | |
| Total Liabilities | $8M | $10M | · | |
| Common Stock | $0 | $0 | · | |
| Paid-in Capital | $369M | $6M | · | |
| Retained Earnings | $-119M | $-105M | · | |
| Stockholders' Equity | $250M | $-99M | · | |
| Liabilities + Equity | $258M | $116M | · | |
| Shares Outstanding | 33,432,555 | 2,203,620 | · |
Cash Flow 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Stock-based Comp | $2M | · | $345.0K | |
| Operating Cash Flow | $-14M | · | $-8M | |
| CapEx | $676.0K | · | $164.0K | |
| Investing Cash Flow | $-2M | · | $-164.0K | |
| Financing Cash Flow | $158M | · | $50M | |
| Net Change in Cash | $143M | · | $42M | |
| Taxes Paid | $0 | · | $4.0K | |
| Free Cash Flow | $-14M | · | · |
Profitability 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| ROA | -10.7% | · | · | |
| ROE | -11.1% | · | · | |
| ROIC | -6.2% | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 38.0 | · | · | |
| Quick Ratio | 35.8 | · | · |
Valuation (TTM) 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Market Cap | $866M | · | · | |
| P/B | 3.5 | · | · | |
| P / Tangible Book | 3.5 | · | · | |
| P / Cash Flow | -64.0 | · | · | |
| P / FCF | -60.9 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $-40M | $-29M |
| Diluted EPS | $-17.98 | $-16.31 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 12.7 | — |
| Quick Ratio | 11.2 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Free Cash Flow | $-33M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.